MRSO, Inc. (JP:5619)
:5619
Top Page
MRSO, Inc.
(5619)
Select Model
Select Model
Rating:45Neutral
Price Target:
¥828.00
▼(-15.51% Downside)
Action:ReiteratedDate:03/24/26
The score is held down primarily by deteriorating operating performance (revenue contraction, losses) and negative operating/free cash flow. A strong, low-debt balance sheet partially offsets these risks, but technical indicators remain bearish and valuation support is limited due to negative earnings and no dividend data.
Positive Factors
Strong balance sheet / Low leverage
Near-zero leverage and a large equity base materially reduce financial risk and provide durable flexibility. Over a multi-month horizon this balance-sheet strength supports funding for operations, product development or strategic actions without urgent refinancing pressure.
Negative Factors
Sustained revenue contraction
Persistent top-line decline erodes operating leverage and market position. Over months this reduces sustainable margins, makes fixed costs harder to cover, and indicates weakening product demand or competitive loss that must be addressed to restore durable growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet / Low leverage
Near-zero leverage and a large equity base materially reduce financial risk and provide durable flexibility. Over a multi-month horizon this balance-sheet strength supports funding for operations, product development or strategic actions without urgent refinancing pressure.
Read all positive factors
MRSO, Inc. (5619) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥3.17B
Dividend YieldN/A
Average Volume (3M)3.21K
Price to Earnings (P/E)―
Beta (1Y)0.18
Revenue GrowthN/A
EPS GrowthN/A
CountryJP
Employees21
SectorHealthcare
Sector Strength45
IndustrySoftware - Application
Share Statistics
EPS (TTM)4.09
Shares Outstanding3,552,750
10 Day Avg. Volume5,480
30 Day Avg. Volume3,213
Financial Highlights & Ratios
PEG Ratio1.09
Price to Book (P/B)1.58
Price to Sales (P/S)2.85
P/FCF Ratio-120.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MRSO, Inc. Business Overview & Revenue Model
Company Description
MRSO, Inc. operates a platform that manages reservations for medical check-ups. It offers Health Care Plat Form (HCPF), DX, and Large-scale vaccination services. HCPF service offers medical checkup and medical checkup online reservation service by...
MRSO, Inc. Financial Statement Overview
Summary
Income Statement
32
Negative
Balance Sheet
82
Very Positive
Cash Flow
28
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.08B | 1.33B | 1.81B | 2.25B | 1.74B |
| Gross Profit | 823.72M | 1.03B | 1.45B | 1.79B | 1.35B |
| EBITDA | -30.03M | 163.77M | 612.32M | 1.01B | 914.67M |
| Net Income | -23.00M | 101.00M | 387.55M | 653.83M | 650.88M |
Balance Sheet | |||||
| Total Assets | 2.12B | 2.26B | 2.25B | 2.08B | 1.70B |
| Cash, Cash Equivalents and Short-Term Investments | 1.68B | 1.81B | 1.93B | 1.74B | 1.42B |
| Total Debt | 0.00 | 7.37M | 15.36M | 23.35M | 31.34M |
| Total Liabilities | 167.50M | 234.45M | 373.01M | 744.00M | 655.32M |
| Stockholders Equity | 1.95B | 2.02B | 1.88B | 1.34B | 1.04B |
Cash Flow | |||||
| Free Cash Flow | -25.59M | -77.63M | 43.06M | 695.05M | 1.10B |
| Operating Cash Flow | -25.35M | -77.63M | 48.28M | 696.31M | 1.11B |
| Investing Cash Flow | -50.23M | -59.69M | -8.31M | -1.43M | -12.95M |
| Financing Cash Flow | -56.67M | 22.89M | 144.36M | -367.99M | -7.99M |
MRSO, Inc. Technical Analysis
Positive
980.00
Price Trends
881.24
Positive
904.64
Negative
969.98
Negative
Market Momentum
-5.93
Negative
59.91
Neutral
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5619, the sentiment is Positive. The current price of 980 is above the 20-day moving average (MA) of 868.10, above the 50-day MA of 881.24, and above the 200-day MA of 969.98, indicating a neutral trend. The MACD of -5.93 indicates Negative momentum. The RSI at 59.91 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:5619.
MRSO, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥6.04B | 21.40 | ― | 0.57% | 21.03% | 32.29% | |
64 Neutral | ¥32.78B | 20.10 | ― | ― | 27.97% | -5.25% | |
60 Neutral | ¥6.46B | 27.15 | ― | ― | 11.32% | ― | |
58 Neutral | ¥11.45B | 74.58 | ― | ― | 14.63% | -760.87% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | ¥3.13B | -2.68 | -233.58% | ― | -8.32% | 71.98% | |
45 Neutral | ¥3.17B | -133.58 | ― | ― | ― | ― |
* Healthcare Sector Average
JP:5619
MRSO, Inc.
892.00
-134.00
-13.06%
JP:3681
V-cube
121.00
-65.00
-34.95%
JP:4060
rakumo Inc.
1,036.00
209.51
25.35%
JP:4397
TeamSpirit, Inc.
391.00
-37.00
-8.64%
JP:4448
Chatwork Co.Ltd.
271.00
-185.00
-40.57%
JP:4477
BASE, Inc.
278.00
-154.69
-35.75%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.